Application of unsupervised and supervised learning to a material attribute database of tablets produced at two different granulation scales.

Journal: International journal of pharmaceutics
PMID:

Abstract

The purpose of this study is to demonstrate the usefulness of machine learning (ML) for analyzing a material attribute database from tablets produced at different granulation scales. High shear wet granulators (scale 30 g and 1000 g) were used and data were collected according to the design of experiments at different scales. In total, 38 different tablets were prepared, and the tensile strength (TS) and dissolution rate after 10 min (DS10) were measured. In addition, 15 material attributes (MAs) related to particle size distribution, bulk density, elasticity, plasticity, surface properties, and moisture content of granules were evaluated. By using unsupervised learning including principal component analysis and hierarchical cluster analysis, the regions of tablets produced at each scale were visualized. Subsequently, supervised learning with feature selection including partial least squares regression with variable importance in projection and elastic net were applied. The constructed models could predict the TS and DS10 from the MAs and the compression force with high accuracy (R= 0.777 and 0.748, respectively), independent of scale. In addition, important factors were successfully identified. ML can be used for better understanding of similarity/dissimilarity between scales, for constructing predictive models of critical quality attributes, and for determining critical factors.

Authors

  • Yoshihiro Hayashi
    Pharmaceutical Technology Division, Nichi-Iko Pharmaceutical Co., Ltd., 205-1, Shimoumezawa, Namerikawa-shi, Toyama 936-0857, Japan; Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan. Electronic address: yoshihiro-hayashi@nichiiko.co.jp.
  • Miho Noguchi
    Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani Toyama-shi, Toyama 930-0194, Japan.
  • Takuya Oishi
    Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Takashi Ono
    Toyama Pharmaceutical Technology Department, Pharmaceutical Technology, 15 Management Department, Production Division, Nichi-Iko Pharmaceutical Co. Ltd, 205-1, Shimoumezawa Namerikawa-shi, Toyama 936-0857, Japan.
  • Kotaro Okada
    Department of Pharmaceutical Technology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama-shi, Toyama 930-0194, Japan.
  • Yoshinori Onuki
    Department of Pharmaceutics, Hoshi University, 2-4-41 Ebara, Shinagawa, Tokyo 142-8501 Japan.